相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patterns of care and outcome for patients with glioblastoma diagnosed during 20082010 in Spain
Francesc Graus et al.
NEURO-ONCOLOGY (2013)
Epidemiology of glial and non-glial brain tumours in Europe
Emanuele Crocetti et al.
EUROPEAN JOURNAL OF CANCER (2012)
Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression
Nadia Malkoun et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme
Gloria B. Roldan Urgoiti et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
Benefit of a prolonged adjuvant treatment with temozolomide for the management of patients with glioblastoma
N. Malkoun et al.
CANCER RADIOTHERAPIE (2011)
Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994-2005
Rafael Fuentes-Raspall et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Controversies in the Adjuvant Therapy of High-Grade Gliomas
Matthias Holdhoff et al.
ONCOLOGIST (2011)
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2010)
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2010)
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2010)
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004
Luc Bauchet et al.
NEURO-ONCOLOGY (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Adjuvant temozolomide: how long and how much?
Enrico Franceschi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Dieto Brandsma et al.
LANCET ONCOLOGY (2008)
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
Alba A. Brandes et al.
NEURO-ONCOLOGY (2008)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
M Brada et al.
ANNALS OF ONCOLOGY (2001)
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
WKA Yung et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
